Adverse effects of topical antiglaucoma drugs.
D001285:Atropine / Q000627:therapeutic use; D002386:Cataract / Q000139:chemically induced; D004456:Echothiophate Iodide / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced; D006801:Humans; D007531:Isoflurophate / Q000009:adverse effects*; D009388:Neostigmine / Q000009:adverse effects*; D010830:Physostigmine / Q000009:adverse effects*; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects*
D011220:Pralidoxime Compounds; D000644:Quaternary Ammonium Compounds; D007531:Isoflurophate; D009388:Neostigmine; D001285:Atropine; D010830:Physostigmine; D004456:Echothiophate Iodide